Radiology and Oncology’s Post

📅 SAVE THE DATE: September 12th, 9AM EST Join us and our partners at Revvity for an exclusive webinar featuring top experts Dr. Martin Engel from Inventia and Dr. James Hunt from Revvity, as we dive into the world of Phenotypic Profiling. 🔍 What You’ll Learn: - Cutting-edge techniques in 3D cancer culture integration with cell painting and high-content imaging - Simplified workflows with minimal protocol adjustments - How these advancements are driving actionable insights in drug discovery Secure your spot now and stay ahead in drug discovery: https://lnkd.in/g9EmFuH6 #DrugDiscovery #3DModeling

🌟 Celebrating a breakthrough in Spatial Multiomics! 🌟 We're thrilled to share the preprint from Tan et al. in npj Precision Oncology, where Discovery Multiomics on GeoMx DSP were used to unlock new biomarker discoveries in mucosal head and neck squamous cell carcinoma (HNSCC). This study showcases how Spatial Multiomics can provide rapid insights that correlate with improved patient outcomes. 🔬💡 Spatial Multiomics with GeoMx DSP allows researchers to uncover biology-driven insights that could be missed by single-analyte approaches. Ready to see how GeoMx DSP’s robust tissue exploration can transform your research? Discover what GeoMx DSP can do for you! 👉 https://lnkd.in/epvq3AW3 #SpatialBiology #SpatialMultiomics #GeoMxDSP #HeadAndNeckCancer #BiomarkerDiscovery

By leveraging high-quality, pre-characterized dissociated tumor cells (DTCs) and matched biospecimen sets, Discovery routinely helps tumor modeling researchers uncover insights into tumor cell dynamics and microenvironment interactions that play roles in tumor growth, invasion, and drug responses.      https://lnkd.in/grrxztvw Our DTCs are characterized for key oncology-relevant biomarkers, including PD-L1, MSI, MMR, BRAF, EGFR, KRAS, NRAS, and HPV, sourced from over 1,000 patient cases.  Reserve your samples today! #tumormodeling #oncology #cancerresearch 

Circulating tumor DNA (ctDNA) analysis has transformed personalized oncology, providing information about tumor dynamics and characteristics. However, the clinical use of ctDNA faces several challenges, including DNA instability, background noise, and false positives. The following table highlights advanced tools and technologies developed to address these challenges, resulting in more precise and sensitive detection of ctDNA. #ctDNA #cfDNA #LiquidBiopsy https://lnkd.in/gKq3Rxqf

Our cryopreserved 3D tumor platform ARCTis is a fantastic tool to accelerate oncology research using uniform, scaffold-free, and easy to handle 3D microtissues. The video below is not only covering ARCTis -- it's also the first one taken in our new office and lab extension in the neighboring building. InSphero grows quickly and I am greatful to our partners and customers for walking with path with us! #insphero #3dcellculture #preclinical #invitro #cancerresearch

New Blog Post from TD2! Explore how Aura Imaging Software 4.0 enhances preclinical oncology research. Our latest post explains how this advanced software improves imaging precision and clarity, providing detailed insights into tumor biology and treatment responses. Learn about the key features of Aura 4.0, including Smart Exposure, high-quality luminescence and fluorescence imaging, advanced data analysis tools, and seamless integration with the Spectral Instruments Imaging AMI HTX. See how TD2's cutting-edge technologies and expertise are advancing cancer research. Read more: https://hubs.li/Q02KBv_b0 #OncologyResearch #PreclinicalStudies #CancerResearch #ImagingSoftware #TD2

Planning on conducting #OrthotopicTumorModels? #InVivoImaging will be critical! Happy to discuss how Translational Drug Development (TD2)'s expertise and experience can help efficiently advance your therapeutic from #BenchToBedside DM or email (mkoratich@td2inc.com) & #HaveAGreatDay #HAGD !!!

📣It is almost time to head over Texas Oncology's session at 3:45pm CT! Join industry experts Lori Brisbin-Ferraro, VP of Precision Medicine Texas Oncology, and Trey Schuchart, Director of Precision Medicine IT Products & Services Texas Oncology for their session on "Precision Oncology: Serving Urban, Suburban, and Rural Areas with Integrated Pathology, Imaging, and Precision Genomics Services." Learn how ELLKAY's trustworthy platform allows them to visualize data like never before! #ExecutiveWarCollege2024

Promising results from a Phase 1 study in Nature Medicine investigating an individualized neoantigen-specific immunotherapy in combination with checkpoint inhibitors for patients with advanced solid tumors! [Link to publication: https://lnkd.in/g4cJ46KN] An interim analysis shows well-tolerated treatment and the induction of robust T cell responses targeting multiple tumor-specific antigens (neoantigens) in a significant portion of patients. Excited that our technology supported the identification and deep characterization of these neoantigen-specific T cells in patient blood samples collected over time. Congratulations to all the researchers and teams involved in this important study! #immunotherapy #cancerresearch #immuneprofiling